Healthcare Market News (Parliament) June 1998The Secretary of State for Health was asked (Hansard 2 June 1998 at column 177) what mechanisms exist to assess, monitor and regulate price increases in drugs used by the NHS. Mr Milburn replied that the prices of branded medicines sold to the NHS are regulated through the pharmaceutical price…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
